WallStreetZenWallStreetZen
NASDAQ: PCRX

How to Buy Pacira Biosciences Stock

Open Broker Account

Pacira Biosciences Inc

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States.

Pacira Biosciences stock last closed at $47.23, down 2.11% from the previous day, and has decreased 11.37% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.27 percentage points. Pacira Biosciences stock is currently +2.61% from its 52-week low of $46.03, and -42.51% from its 52-week high of $82.16.

There are currently 45.88M PCRX shares outstanding. The market capitalization of PCRX is $2.17B. In the past 24 hours, 508,413 PCRX shares were traded.

How to Buy Pacira Biosciences Stock

Not sure how to invest in Pacira Biosciences stock? Here's how.
  1. Figure out where to buy Pacira Biosciences stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Pacira Biosciences stock.
  2. Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected. It's the best place to buy PCRX stock.
  3. Deposit funds into your investment account: Pick your payment method and add your information.
  4. Analyze Pacira Biosciences stock: The Pacira Biosciences ticker symbol is PCRX. Is Pacira Biosciences stock a good investment? Should you buy shares of PCRX? How do PCRX's underlying business fundamentals look? Do top analysts think Pacira Biosciences is a good buy? Why has PCRX's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if PCRX is a good stock to buy).
  5. Execute your PCRX buy order: Decide if you will purchase PCRX shares at the current market price or use a limit order to buy PCRX stock at a given price.
  6. Monitor your PCRX position: Create a watchlist to important updates regarding your investment in Pacira Biosciences shares.

Step 1: Figure out where to buy Pacira Biosciences stock

You need an online brokerage account to access the NASDAQ market and buy PCRX stock.

A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best online stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world financial markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by opening an account with eToro now.

Open eToro Account

Step 2: Open a brokerage account

Now that you've selected the right brokerage, it's time to fill out some personal info so you can invest in PCRX stock today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
  2. Provide your personal data to create a new brokerage account.
  1. Submit your application by clicking the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your investment account

Watch the video below to see the process of transferring funds into your new brokerage account.

Get started with eToro today

Step 4: Analyze Pacira Biosciences stock

It's very important to evaluate stocks before you buy, so you actually wrap your head around the risk and upside.

Pacira Biosciences quick stats

PCRX Price
$47.23
1w %
-4.95%
1y %
-11.37%
5y %
4.38%
P/E
104.96x
P/B
2.81x
P/S
3.31x
PEG
0.81x
Revenue
$654.06M
Earnings
$20.88M
Fore. Rev. Growth
12.78%
Fore. Earn. Growth
128.94%
Market Cap
$2.17B
Next Earnings
N/A
Next Dividend
N/A

Pacira Biosciences Due Diligence Checks

WallStreetZen was created to help average investors perform better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on PCRX's stock page.

Is PCRX stock properly valued?

Analysts use many financial metrics, analyses, models, and charts to gauge PCRX's intrinsic value.

Using relative valuations methods:

  • PCRX may be overvalued based on its P/E ratio of 104.96x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 19.61x
  • PCRX may be overvalued based on its P/B ratio of 2.81x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.81x
  • PCRX could be undervalued based on its PEG ratio of 0.81x

You can access more valuation analysis on PCRX's stock here.

How do PCRX Financials look?

Passed Financial Due Diligence Checks:

  • Total PCRX debt is lower than 5 years ago, relative to shareholder equity.
  • There are more short-term assets than short-term liabilities on the PCRX balance sheet.

Failed Financial Due Diligence Checks:

  • PCRX profit margin has gone down from 12% to 3.2% in the past year.
  • PCRX earnings of $64.53M is not sufficient to cover its interest payments.
  • PCRX has a relatively high debt to equity ratio of 1.25.
  • PCRX's operating cash flow of $126.45M allows it to safely service it's debt of $821.64M.
  • There are more long-term liabilities than short-term assets on the PCRX balance sheet.

Is it a good time to buy Pacira Biosciences stock, according to Wall Street analysts?

Out of 6 Equities analysts who research PCRX, the consensus analyst rating on PCRX is a Buy

Should I buy or sell PCRX stock?

Based on 6 analysts offering ratings for Pacira Biosciences Inc.
Buy
Strong Buy
2 analysts 33.33%
Buy
3 analysts 50%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Latest PCRX Analyst Recommendations

Gary Nachman, a bottom 13% analyst from BMO Capital maintains PCRX with a hold rating and lowers their PCRX price target from $66.00 to $60.00, on Nov 7, 2022.

Oren Livnat, a bottom 4% analyst from HC Wainwright & Co. maintains PCRX with a buy rating and lowers their PCRX price target from $83.00 to $76.00, on Nov 4, 2022.

Serge Belanger, a bottom 30% analyst from Needham maintains PCRX with a buy rating and lowers their PCRX price target from $76.00 to $74.00, on Nov 3, 2022.

Glen Santangelo, a top 30% analyst from Jefferies assumes PCRX with a strong buy rating and announces their PCRX price target of $66.00, on Oct 21, 2022.

David Amsellem, a top 11% analyst from Piper Sandler maintains PCRX with a strong buy rating and lowers their PCRX price target from $84.00 to $80.00, on Jul 21, 2022.

You can dig deeper into what analysts are projecting on the Pacira Biosciences stock forecast page.

PCRX Technicals

SMA10
48.41
SMA20
49.28
SMA50
51.81
SMA100
53.75
SMA200
60.09
MACD
-1.19
MACD Signal
-1.12
MACD Histogram
-0.07
RSI
39.01
Stochastic %K
21.37
Stochastic %D
25.19
StochRSI %K
27.83
StochRSI %D
29.79

Is PCRX Growing Revenue?

Last year, PCRX earnings were $20.88M. In the past three year, PCRX's earnings have grown by 200% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.81%.

Last year, PCRX revenue was $654.06M. Over the past 5 year, PCRX's revenue has increased by 18.45% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 44.46%.

Dig into PCRX's earnings and revenue performance here.

Are PCRX executives and large shareholders buying or selling the stock?

In the past year, executives and large shareholders at PCRX have bought more shares than they have sold.

Max Reinhardt, President Rest of World of PCRX, was the latest PCRX insider to sell. They sold $80,040.00 worth of PCRX shares on Oct 7, 2022.

Research more about who owns PCRX shares here.

Does PCRX stock generate passive income?

No, Pacira Biosciences doesn't provide an income stream by paying out dividends.

Get analysis from other traders

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Execute your PCRX buy order

You have two primary options:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly sufficient.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at an exact price, use a limit order.

Click the Open Trade button and your broker will execute your order.

If you want additional info about buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Monitor your PCRX position

Now that you own some PCRX shares, you'll want to stay up-to-date on your new company.

Create a watchlist to track the most important metrics related to your PCRX stock.

PCRX Feed

How to Buy Stock in Pacira Biosciences

To reiterate, here are the 6 steps you need to take to buy Pacira Biosciences stock right now:

  1. Figure out where to buy Pacira Biosciences stock
  2. Open a brokerage account
  3. Deposit funds into your investment account
  4. Analyze Pacira Biosciences stock
  5. Execute your PCRX buy order
  6. Monitor your PCRX position

If you are looking for a brokerage, eToro is our favorite venue.

Get Started with eToro Today

If you would like to get the latest scoop on your investment in Pacira Biosciences, create your watchlist below.

NASDAQ: PCRX
$47.23-1.02 (-2.11%)
Updated Dec 1, 2022
Open eToro Account
NASDAQ: PCRX
$47.23-1.02 (-2.11%)
Updated Dec 1, 2022
Open eToro Account

FAQ

How much does it cost to buy one Pacira Biosciences share?

As of Dec 1, 2022, it costs $47.23 to buy one share of Pacira Biosciences stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.212 shares of PCRX.

Get Started with eToro Today

Is now a good time to buy Pacira Biosciences stock?

According to 6 Wall Street analysts who monitor Pacira Biosciences, their consensus recommendation is to buy Pacira Biosciences stock.

What is the best way to buy Pacira Biosciences stock?

The best way to buy Pacira Biosciences stock is within a brokerage account on eToro.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.